World
Kimberly-Clark Sued over Ebola Protection Gowns

Class-action lawsuit alleges company misled the health care industry

 

A California doctor is suing Kleenex maker Kimberly-Clark for more than $500 million for allegedly misleading health care professionals into believing that one of its surgical gowns provided a superior amount of protection against exposure to Ebola — despite the fact that many of the gowns experienced “catastrophic failures” during product safety tests.


The class-action lawsuit claims that Kimberly-Clark knew as early as 2013 that its MICROCOOL Breathable High Performance Surgical Gowns were unsafe and thus put doctors and patients at “serious risk” of exposure to Ebola, among other diseases transmissible through bodily fluids. Despite this knowledge, the lawsuit states that the company continued to market the gowns to the health care industry.


Kimberly-Clark started selling the gowns in 2011 and controls more than 50 percent of the surgical gown market, according to the lawsuit. The company has sold millions of the gowns, lead attorney Michael Avenatti told Reuters.


“Kimberly-Clark needs to immediately recall these gowns and come clean with the FDA, CDC, healthcare professionals and the general public,” Avenatti said in a statement, according to Reuters. “The risks associated with continued concealment of the truth are far too great.”


The company told TINA.org that it does not comment on pending litigation.


Click here for more of our coverage on the marketing of Ebola-related products.

 

Courtesy: TruthInAdvertising.org

User

AT&T Stops Using Undeletable Phone Tracking IDs

Verizon remains committed to its program of inserting a tracking number into its customers’ cellphone transmissions

 

AT&T says it has stopped its controversial practice of adding a hidden, undeletable tracking number to its mobile customers' Internet activity.


"It has been phased off our network," said Emily J. Edmonds, an AT&T spokeswoman.


The move comes after AT&T and Verizon received a slew of critical news coverage for inserting tracking numbers into their subscribers' Internet activity, even after users opted out. Last month, ProPublica reported that Twitter's mobile advertising unit was enabling its clients to use the Verizon identifier. The tracking numbers can be used by sites to build a dossier about a person's behavior on mobile devices – including which apps they use, what sites they visit and for how long.


The controversial type of tracking is used to monitor users' behavior on their mobile devices where traditional tracking cookies are not as effective. The way it works is that a telecommunications carrier inserts a uniquely identifying number into all the Web traffic that transmits from a users' phone.


AT&T said it used the tracking numbers as part of a test, which it has now completed.
Edmonds said AT&T may still launch a program to sell data collected by its tracking number, but that if and when it does, "customers will be able to opt out of the ad program and not have the numeric code inserted on their device."


A Verizon spokeswoman says its tracking program is still continuing, but added "as with any program, we're constantly evaluating."


Verizon uses the tracking number to identify the users' behavior and offer advertisers insights about users gleaned from that data. Verizon says the data it sells is not tied to a users' identity. "None of the data that is used in the program is personally-identifiable," the company said when it updated its privacy policy in 2012.


Verizon offers its customers an opportunity to opt out of the program. But opting out doesn't remove the tracking ID.

 

Courtesy: ProPublica.org

User

The Nocebo Effect

The anticipation of disaster is often worse than the disaster itself

 

Ellen Langer is probably the longest serving psychologist at Harvard, at 67 years. No one, to date, has done as much research as she has on the connection between the human mind and disease.

 

Her research has brought to light the vital role that mind plays in causing as well as curing disease. She is the one who gave respectability to the placebo effect—the good that a positive mindset can do for the body. She showed that the fear of disease and negative prognoses, especially in cancer and heart disease, are among the most important factors that interfere with the body’s healing capacity, also termed the ‘Nocebo’ effect.

 
One case report is very significant. There was a middle-aged man who came for a check-up; his routine chest X-ray showed a coin lesion—a small rounded shadow whose details were not clear.
 
The doctors told him, in no uncertain terms, that the ‘coin lesion’ was due to cancer and needed further probing. The man got admitted and, to cut a long story short, he was dead in six months due to fast spreading lung cancer. These should not be called cancers. They have a new name—incidentalomas.
 
One of his relatives was a doctor who happened to look at his miniature chest X-ray taken 30 years earlier when he joined his government job. The coin lesion was there at the same place.
 
The moral of the story is that if that coin were malignant, he would have died long ago. The minute his mind was given the Nocebo signal, the cancer started growing very fast, to kill him in six months. That shows the power of the mind over the body. Both have now been shown to be two faces of the same coin.
 
Langer’s recent study tried to quantify the Nocebo effect. “In that study her staff will encourage the women to think anew about their circumstances in an attempt to purge any negative messages they have absorbed during their passage through the medical system.” This is crucial, Langer says, because just as the mind can make things better, it can also make things worse. The Nocebo effect is the flip side of the more positive placebo effect; she says that one of the most pernicious Nocebo effects can occur when a patient is informed by her doctor that she is ill. The diagnosis itself, Langer says, primes the symptoms the patient expects to feel. “You change a word here or there, and you get vastly different results,” Langer says. She told scientists about a yet-to-be-published study she did in 2010, that found breast-cancer survivors who described themselves as ‘in remission’ were less functional and showed poorer general health and more pain than subjects who considered themselves ‘cured’.
 
Another patient of mine comes to mind. The septuagenarian former governor of Karnataka had his routine check-up with an illustrious Delhi cardiologist, who saw his ECG (electro-cardiogram). He pronounced that the old man had serious heart disease and needed an urgent angiogram and may be either an angioplasty or a bypass after that. Someone told him to see me.
 
I found that the anomaly was seen even in his ECG report taken 35 years ago.
 
When I told him that he needs no treatment, as this must have been a condition that he was born with, his doubt remained because his other cardiologist was an illustrious one and could not have been so wrong! I took the two readings and explained the changes in great detail to him, showing him that whatever ‘serious disease’ he was supposed to have had was there 35 years ago also. If he could be active and working for 35 years with the block, he could go on for another 35 years.
 
His face brightened and he is still alive, kicking and active! Removing his Nocebo effect did the trick.
 
May I earnestly appeal to our colleagues not to frighten patients with Nocebo thoughts in the first place?
 
‘You have cancer and only six months to live’; 'if you do not get angioplasty right now you might die on your way home’. Some cancerologists argue that they have to tell the patient the truth.
 
Where is the truth in their statement? Science does not know what cancer is? How do we so confidently give the patient a death warrant? Even if one has to tell a small lie to avoid a Nocebo situation that might save a life, it might be worth weighing our words, before we speak as doctors.
 
“The art of medicine consists in amusing the patient while nature cures the disease.”Voltaire
 
(Professor Dr BM Hegde, a Padma Bhushan awardee in 2010, is an MD, PhD, FRCP (London, Edinburgh, Glasgow & Dublin), FACC and FAMS.)

User

We are listening!

Solve the equation and enter in the Captcha field.
  Loading...
Close

To continue


Please
Sign Up or Sign In
with

Email
Close

To continue


Please
Sign Up or Sign In
with

Email

BUY NOW

The Scam
24 Year Of The Scam: The Perennial Bestseller, reads like a Thriller!
Moneylife Magazine
Fiercely independent and pro-consumer information on personal finance
Stockletters in 3 Flavours
Outstanding research that beats mutual funds year after year
MAS: Complete Online Financial Advisory
(Includes Moneylife Magazine and Lion Stockletter)